Skip to content

Clinical trials

Observational Diabetes Mellitus trials in Russia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Diabetes Mellitus Phase: Observational Country / region: Russia Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20073
20082
20092
20101
20111
20123
20151
20161
20171
20182
20191
20202
20221
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed22
Enrolling by invitation2
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novo Nordisk A/S7
Eurasian Association of Therapists3
Bayer2
Abbott1
AstraZeneca1
Eli Lilly and Company1
Endocrinology Research Centre, Moscow1
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health1
Mannkind Corporation1
Medical University of Vienna1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Diabetes Mellitus26
Diabetes Mellitus, Type 210
Hypertension6
Diabetes Mellitus, Type 15
Obesity5
Pulmonary Disease, Chronic Obstructive5
Asthma3
COVID-193
Coronary Disease3
Overweight3

Trials

Showing 1 to 25 of 26. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.